Metformin alleviates reactive gliosis and neurodegeneration, improving cognitive deficit in a rat model of temporal lobe epilepsy
Brain Research · 2024-12 · 1844 · 149138
DOI: 10.1016/j.brainres.2024.149138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2024-12. Verfasst von Sree Lalitha Bojja und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India. Hauptthemen laut MEDLINE: Metformin, Epilepsy, Temporal Lobe, Cognitive Dysfunction, Gliosis. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
Cognitive impairment is a prevalent co-morbidity associated with epilepsy. Emerging studies indicate that neuroinflammation could be a possible link between epilepsy and its comorbidities, including cognitive impairment. In this context, the roles of glial activation, proinflammatory mediators, and neuronal death have been well studied and correlated with epilepsy-associated cognitive impairment in animal studies. While recent reports have demonstrated the anti-epileptogenic and anti-convulsant actions of metformin, its effect on epilepsy associated cognitive deficit remains unknown. Therefore, the current study investigated the effect of metformin treatment on neuroinflammation, neurodegeneration, and cognitive deficits after inducing status epilepticus (SE) with lithium-pilocarpine in rats. Metformin treatment improved the hippocampal-dependent spatial and recognition memory in Morris water maze and Novel object recognition tasks, respectively. Further, metformin treatment attenuated microglial and astroglial activation, accompanied by reduced IL-1β, COX-2 and NF-ĸβ gene expression. Additionally, metformin conferred neuroprotection by inhibiting the neuronal death as assessed by Nissl staining and transmission electron microscopy. These findings suggest that metformin holds promise as a therapeutic intervention for cognitive impairment associated with epilepsy, possibly through its modulation of glial activation and neuronal survival. Further research is needed to elucidate the precise mechanisms and to assess the long-term effect of metformin in epilepsy-associated cognitive impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
- Department of Immunopathology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India.
- Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India. Electronic address: drbikashus@yahoo.com.
Förderung
- Department of Biotechnology, Ministry of Science and Technology, India
- Council of Scientific and Industrial Research, India
Zitieren
APA
Bojja, S. L., Anand, S., Minz, R. W., & Medhi, B. (2024). Metformin alleviates reactive gliosis and neurodegeneration, improving cognitive deficit in a rat model of temporal lobe epilepsy. Brain Research, 1844, 149138. https://doi.org/10.1016/j.brainres.2024.149138
Vancouver
Bojja SL, Anand S, Minz RW, Medhi B. Metformin alleviates reactive gliosis and neurodegeneration, improving cognitive deficit in a rat model of temporal lobe epilepsy. Brain Research. 2024;1844:149138. doi:10.1016/j.brainres.2024.149138
BibTeX
@article{Bojja2024,
author = {Bojja, Sree Lalitha and Anand, Shashi and Minz, Ranjana W and Medhi, Bikash},
title = {Metformin alleviates reactive gliosis and neurodegeneration, improving cognitive deficit in a rat model of temporal lobe epilepsy},
journal = {Brain Research},
year = {2024},
volume = {1844},
pages = {149138},
doi = {10.1016/j.brainres.2024.149138}
}
EUVIMED